Pharma Journalist 9038 posts 0 comments

Immune Regulation Ltd, a US and UK based clinical stage biotechnology company, announced that it has received a notice of allowance from the U.S. Patent and Trademark Office (USPTO) for…
Read More...

AnHeart Therapeutics, Co., Ltd. a clinical stage oncology company focused on underserved patients in global markets, has through its subsidiary AnHeart Therapeutics Inc. entered into…
Read More...

Grifols announced it has entered into a transaction to acquire the remaining equity of Alkahest, Inc. in exchange for a total price of $146 million, on a debt-free basis. No additional…
Read More...

Destiny Pharma plc, a clinical stage biotechnology company focused on the development of novel, hospital infection prevention treatments that address the global challenge of…
Read More...

IcanoMAB, a privately-funded biotech company focusing on the pre-clinical and clinical development of novel precision canonical antibodies for the treatment of cancer, immune-system…
Read More...

SMi reports: HEUFT to host a free exclusive webinar Pulsed x-ray technology & smart optics for a total inspection of pre-fillable syringe cannulas and needle shields, taking place…
Read More...

Kite, a Gilead Company announced that it has submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for Yescarta (axicabtagene…
Read More...

AbbVie and I-Mab announced that AbbVie and I-Mab have signed a broad, global collaboration agreement for the development and commercialization of lemzoparlimab (also known as TJC4), an…
Read More...

Ehave, Inc. a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced it is entering into a licensing agreement with a telemedicine…
Read More...

PPD, Inc. and Lupus Therapeutics (LT), an affiliate of the Lupus Research Alliance known for its lupus clinical trials expertise, have entered into a collaboration to expand and enhance…
Read More...